跳转至内容
Merck
CN
  • Enzymes involved in a novel anaerobic cyclohexane carboxylic acid degradation pathway.

Enzymes involved in a novel anaerobic cyclohexane carboxylic acid degradation pathway.

Journal of bacteriology (2014-08-13)
Johannes W Kung, Anne-Katrin Meier, Mario Mergelsberg, Matthias Boll
摘要

The anaerobic degradation of cyclohexane carboxylic acid (CHC) has so far been studied only in Rhodopseudomonas palustris, in which CHC is activated to cyclohexanoyl coenzyme A (cyclohexanoyl-CoA [CHCoA]) and then dehydrogenated to cyclohex-1-ene-1-carboxyl-CoA (CHeneCoA). This intermediate is further degraded by reactions of the R. palustris-specific benzoyl-CoA degradation pathway of aromatic compounds. However, CHeneCoA is not an intermediate in the degradation of aromatic compounds in all other known anaerobic bacteria; consequently, degradation of CHC was mostly unknown in anaerobic bacteria. We identified a previously unknown CHC degradation pathway in the Fe(III)-reducing Geobacter metallireducens by determining the following CHC-induced in vitro activities: (i) the activation of CHC to CHCoA by a succinyl-CoA:CHC CoA transferase, (ii) the 1,2-dehydrogenation of CHCoA to CHeneCoA by CHCoA dehydrogenase, and (iii) the unusual 1,4-dehydrogenation of CHeneCoA to cyclohex-1,5-diene-1-carboxyl-CoA. This last represents a previously unknown joint intermediate of the CHC and aromatic compound degradation pathway in bacteria other than R. palustris. The enzymes catalyzing the three reactions were purified and characterized as specific enzymes after heterologous expression of the encoding genes. Quantitative reverse transcription-PCR revealed that expression of these genes was highly induced during growth with CHC but not with benzoate. The newly identified CHC degradation pathway is suggested to be present in nearly all CHC-degrading anaerobic bacteria, including denitrifying, Fe(III)-reducing, sulfate-reducing, and fermenting bacteria. Remarkably, all three CHC degradation pathways always link CHC catabolism to the catabolic pathways of aromatic compounds. We propose that the capacity to use CHC as a carbon source evolved from already-existing aromatic compound degradation pathways.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
咪唑, ReagentPlus®, 99%
Sigma-Aldrich
咪唑, ACS reagent, ≥99% (titration)
Sigma-Aldrich
咪唑, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
咪唑, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
咪唑水溶液, BioUltra, 1 M in H2O
Sigma-Aldrich
咪唑, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
咪唑, ≥99% (titration), crystalline
Sigma-Aldrich
咪唑, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
咪唑, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
咪唑, Pharmaceutical Secondary Standard; Certified Reference Material
USP
咪唑, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
咪唑, ReagentPlus®, 99%, Redi-Dri, free-flowing
咪唑, European Pharmacopoeia (EP) Reference Standard
昂丹司琼杂质E, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
咪唑, Molecular Biology, ≥99% (titration), free-flowing, Redi-Dri
Sigma-Aldrich
咪唑, Vetec, reagent grade, 98%